242 studies found for:    Cerebral Atrophy
Show Display Options
Rank Status Study
21 Completed Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
22 Active, not recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
23 Recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
24 Completed Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Interventions: Drug: natalizumab;   Other: standard of care
25 Active, not recruiting Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention:
26 Recruiting Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Conditions: Atypical Alzheimers Disease;   Logopenic Variant of Primary Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
Intervention: Drug: C-11 PiB
27 Not yet recruiting Automated Brain Morphometry for Dementia Diagnosis
Condition: Dementia
Interventions: Device: Brain Morphometry;   Other: Standard radiological assessment
28 Completed Clinical Findings in General Paresis
Condition: General Paresis
Intervention:
29 Recruiting Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction
Conditions: Postoperative Cognitive Dysfunction;   Delirium;   Dementia
Intervention:
30 Not yet recruiting Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression
Condition: Major Depressive Disorder
Intervention: Behavioral: Problem Solving Therapy
31 Terminated Flupirtine as Oral Treatment in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Flupirtine;   Drug: Placebo
32 Recruiting Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
Condition: Multiple System Atrophy
Interventions: Drug: EGCG as putative neuroprotective agent;   Drug: Placebo
33 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
34 Recruiting MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Amiloride;   Drug: Riluzole;   Drug: Fluoxetine;   Drug: Placebo
35 Terminated
Has Results
Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate;   Drug: Placebo;   Drug: Prednisone
36 Completed Does Glaucoma Cause Loss of Brain Function?
Condition: Glaucoma
Intervention:
37 Recruiting The PACO Study ("Personnalité Alzheimer COmportement")
Condition: Alzheimer Disease
Intervention: Behavioral: questioning
38 Active, not recruiting Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
39 Completed A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Intervention: Drug: Lamotrigine
40 Recruiting The Microvascular Brain Retina And Kidney Study
Condition: Cerebral Small Vessels Disease
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years